Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$5.9B
79M shares
52-week range
$50.82 – $85.84
75% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
NASDAQ
CS
P/S (TTM)
2.7
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
www.radnet.comNo one on the platform currently holds RDNT.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-12-31 | 3,400 | $237.5K |
No one on the platform has traded RDNT yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 11.5% | 13.7% | ||||
| Profit Margin % | -0.9% | 0.4% | 0.6% | |||
| Free Cash Flow Margin % | 4.2% | -0.6% | 1.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +13.2% on the P/E track.
At today's price, your expected annual return is +25.0% on the P/E track.
At today's price, your expected annual return is +36.8% on the P/E track.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$RDNT RadNet’s Digital Health business is growing rapidly as its radiology AI tools gain momentum. Could this medical-imaging stock be hiding a software-style opportunity? https://biotechhealthx.com/biotech-news/radnet-rdnts-ai-revenue-just-surged-56-5-is-rdnt-ready-for-its-next-scan/
View on StockTwits ↗$CERT $GEHC $RDNT $TEM $BFLY Looking for the best AI medicine stocks? These 5 companies are applying artificial intelligence to some of healthcare’s most valuable markets. https://biotechhealthx.com/biotech-news/5-best-cheap-ai-medicine-stocks-to-buy-now/
View on StockTwits ↗
$RDNT I guess only bots post here? Anyway glad I kept a good chunk of my ICAD shares!
View on StockTwits ↗
Wall St is expecting 0.26 EPS for $RDNT Q3 [Reporting 11/08 AMC] http://www.estimize.com/intro/rdnt?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗
https://www.marketbeat.com/earnings/reports/2026-8-10-radnet-inc-stock/ $RDNT RadNet Earnings Transcript
View on StockTwits ↗
$RDNT @Jblack500 @cynicaloptimist @BustaCapital @IsabellaDC @WAJeff @No_Face_character
View on StockTwits ↗
$RDNT: RadNet is higher after beating Q2 expectations and posting record revenue, with advanced imaging volumes accelerating and Digital Health revenue surging 57%. Growing AI adoption is increasingly adding a higher-growth layer to its core imaging business. Full analysis: https://www.briefing.com/story-stocks/archive/2026/8/10/radnet-stock-gets-a-clear-scan-rdnt-delivers-strong-q2-results-and-ai-momentum?utm_campaign=storystocks&utm_medium=social&utm_source=st&utm_content=link #radnet #Earnings #Healthcare #tech #AI
View on StockTwits ↗@Jblack500 @cynicaloptimist @BustaCapital @IsabellaDC @WAJeff @No_Face_character $RDNT
View on StockTwits ↗
$RDNT (+1.9% pre) RadNet Q2 revenue rises 25% to record $622.7 million https://ooc.bz/l/110597
View on StockTwits ↗
$SOL $RDNT $SONY Solana is one of the top-performing cryptocurrencies in early August. It has jumped about 5% since a recent technical upgrade in late July. https://www.earlybird.email/p/solana-simd-0286-upgrade-66-block-compute-increase-explained
View on StockTwits ↗
$RDNT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.10 down -47.37% YoY • Reported revenue of $622.72M up 24.99% YoY • RadNet, Inc. revises its 2026 Imaging Center guidance, now expecting total net revenue of $2,370-$2,420 million, Adjusted EBITDA of $345-$358 million, and Free Cash Flow of $115-$125 million for the full year.
View on StockTwits ↗
$RDNT RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025 622.7M over 610.87M expected
View on StockTwits ↗@Wigglyick might want to take a look! I own $RDNT too but got in through ICAD
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.5B | +24.9% | $0.51 | $0.40–$0.60 | 150.0× | 5 |
| 2027 | $2.8B | +10.8% | $0.89 | $0.75–$1.12 | 87.0× | 4 |
| 2028 | $3.0B | +8.7% | $1.19 | $0.98–$1.53 | 64.8× | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-09 | $0.20 | $0.29 | +44.0% |
| 2026-05-11 | $-0.14 | $-0.28 | -100.0% |
| 2026-03-02 | $0.19 | $0.23 | +21.1% |
| 2025-11-10 | $0.22 | $0.20 | -10.3% |
| 2025-08-11 | $0.17 | $0.31 | +82.4% |
| 2025-05-11 | $-0.17 | $-0.50 | -194.1% |
| 2025-02-27 | $0.15 | $0.07 | -51.6% |
| 2024-11-10 | $0.15 | $0.13 | -13.3% |
| $6.6B |
| — |
| IRTCiRhythm Technologies, Inc. | $112.10 | -2.28% | $3.7B | — |
| KRYSKrystal Biotech, Inc. | $333.75 | -1.85% | $9.8B | — |
Source: Financial Modeling Prep · peers by sector/industry